Create Free Account

By creating account you will get access to hot stocks & personalised emails

Persimmon PLC

Consumer Cyclical GB PSN

1207.0GBP
-15.0(1.23%)

Last update at 2024-12-19T16:38:00Z

Day Range

1197.501225.00
LowHigh

52 Week Range

925.001431.56
LowHigh

Fundamentals

  • Previous Close 1222.00
  • Market Cap4435.16M
  • Volume887761
  • P/E Ratio13.61
  • Dividend Yield5.76%
  • EBITDA448.20M
  • Revenue TTM3315.70M
  • Revenue Per Share TTM10.39
  • Gross Profit TTM 867.50M
  • Diluted EPS TTM1.02

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 730.70M 966.80M 783.80M 1040.80M 1090.80M
Minority interest - - - - -
Net income 561.00M 787.20M 638.40M 848.80M 886.40M
Selling general administrative - - - 107.40M 101.10M
Selling and marketing expenses - - - - -
Gross profit 867.50M 1083.80M 894.40M 1130.70M 1179.90M
Reconciled depreciation 15.80M 14.50M 14.10M 13.30M 10.00M
Ebit 734.80M 970.40M 783.50M 1029.40M 1103.10M
Ebitda 750.60M 984.90M 806.50M 1063.20M 1113.10M
Depreciation and amortization 15.80M 14.50M 23.00M 33.80M 10.00M
Non operating income net other - - - - -
Operating income 734.80M 970.40M 783.50M 1029.40M 1082.70M
Other operating expenses 3090.90M 2650.00M 2544.80M 2620.00M 2654.90M
Interest expense 4.10M 3.60M 8.60M 9.10M 12.30M
Tax provision 169.70M 179.60M 145.40M 192.00M 204.40M
Interest income 6.00M 9.90M 8.90M 7.40M 9.20M
Net interest income 5.80M 6.30M 0.30M 11.40M 8.10M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 169.70M 179.60M 145.40M 192.00M 204.40M
Total revenue 3815.80M 3610.50M 3328.30M 3649.40M 3737.60M
Total operating expenses 142.60M 123.30M 110.90M 101.30M 97.20M
Cost of revenue 2948.30M 2526.70M 2433.90M 2518.70M 2557.70M
Total other income expense net -4.10000M -3.60000M 0.30M 11.40M 8.10M
Discontinued operations - - - - -
Net income from continuing ops 561.00M 787.20M 638.40M 848.80M 886.40M
Net income applicable to common shares 561.00M 787.20M 638.40M 848.80M 886.40M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets - 5034.10M 4792.20M 4623.10M 4489.30M
Intangible assets - 60.00M 60.00M 60.00M 60.00M
Earning assets - - - - -
Other current assets - 221.90M 155.20M 109.40M 67.90M
Total liab - 1594.80M 1167.00M 1104.70M 1231.00M
Total stockholder equity - 3439.30M 3625.20M 3518.40M 3258.30M
Deferred long term liab - - - - -
Other current liab - 142.10M 78.20M 80.50M 84.50M
Common stock - 31.90M 31.90M 31.90M 31.90M
Capital stock - 31.90M 31.90M 31.90M 31.90M
Retained earnings - 2868.50M 3055.10M 2950.90M 2693.90M
Other liab - 492.40M 273.00M 220.40M 225.90M
Good will - 113.00M 115.60M 121.80M 126.10M
Other assets - 195.80M 194.80M 104.00M 150.50M
Cash - 861.60M 1246.60M 1234.10M 843.90M
Cash and equivalents - - - - -
Total current liabilities - 1091.50M 885.20M 874.70M 996.20M
Current deferred revenue - - - - -
Net debt - -861.60000M -1246.60000M -1234.10000M -843.90000M
Short term debt - - - 285.50M -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - 538.90M 538.20M 535.60M 532.50M
Property plant equipment - 118.60M 99.00M 90.40M 82.00M
Total current assets - 4546.40M 4322.50M 4244.80M 4068.60M
Long term investments - - - - 2.10M
Net tangible assets - 3266.30M 3449.60M 3336.60M 3072.20M
Short term investments - - - - -
Net receivables - 153.70M 155.20M 102.80M 61.90M
Long term debt - - - - -
Inventory - 3462.90M 2920.70M 2901.30M 3156.80M
Accounts payable - 949.40M 807.00M 794.20M 911.70M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -96.20000M
Additional paid in capital - - - - -
Common stock total equity - - - 31.90M 31.90M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 185.60M 185.40M 98.40M 146.00M
Deferred long term asset charges - - - - -
Non current assets total - 487.70M 469.70M 378.30M 420.70M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -29.80000M 1.80M -18.10000M 0.90M 0.90M
Change to liabilities 141.10M 37.40M -116.90000M -225.60000M -82.70000M
Total cashflows from investing activities -29.80000M -18.20000M -18.10000M -25.90000M -15.00000M
Net borrowings -3.30000M -3.30000M -3.60000M -3.80000M -3.80000M
Total cash from financing activities -757.50000M -754.10000M -357.20000M -798.30000M -893.90000M
Change to operating activities 13.30M 18.90M 16.40M 31.40M 41.60M
Net income 561.00M 787.20M 638.40M 848.80M 886.40M
Change in cash -385.00000M 12.50M 390.20M -204.20000M -254.60000M
Begin period cash flow 1246.60M 1234.10M 843.90M 1048.10M 1302.70M
End period cash flow 861.60M 1246.60M 1234.10M 843.90M 1048.10M
Total cash from operating activities 402.30M 784.80M 765.50M 620.00M 654.30M
Issuance of capital stock 0.70M 2.60M 0.70M 43.30M 157.10M
Depreciation 15.80M 14.50M 14.10M 13.30M 10.00M
Other cashflows from investing activities - - 0.80M 1.60M 0.50M
Dividends paid 750.10M 749.60M 350.70M 747.80M 732.30M
Change to inventory -532.50000M -9.80000M 265.00M -87.70000M -225.50000M
Change to account receivables -81.10000M -59.50000M -45.80000M 6.30M -26.70000M
Sale purchase of stock -0.70000M - 3.10M 3.90M -1.30000M
Other cashflows from financing activities -7.40000M -7.10000M -7.20000M -7.20000M -3.20000M
Change to netincome 284.70M -3.90000M -5.70000M 33.50M 51.20M
Capital expenditures 30.50M 20.90M 18.90M 27.50M 15.50M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -459.20000M -13.00000M 118.70M -275.60000M -293.30000M
Stock based compensation 9.00M 6.40M 6.40M 3.70M 7.90M
Other non cash items 275.70M -8.10000M -9.00000M -11.30000M -6.40000M
Free cash flow 371.80M 763.90M 746.60M 592.50M 638.80M

Peer Comparison

Sector: Consumer Cyclical Industry: Residential Construction

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PSN
Persimmon PLC		 -15.0 1.23% 1207.00 13.61 16.37 1.33 1.32 1.23 8.71
TW
Taylor Wimpey PLC		 -3.3 2.64% 121.70 9.07 15.41 1.28 1.14 1.13 5.85
BKG
The Berkeley Group Holdings plc		 -56.0 1.41% 3918.00 11.34 13.26 1.99 1.49 1.84 7.23
VTY
Vistry Group PLC		 -6.5 1.00% 646.00 12.94 9.63 1.00 0.95 1.12 10.16
BWY
Bellway PLC		 -36.0 1.49% 2388.00 8.74 20.92 0.90 0.89 0.84 5.47

Reports Covered

Stock Research & News

View All

Profile

Persimmon Plc, together with its subsidiaries, operates as a house builder in the United Kingdom. The company offers family housing under the Persimmon Homes brand name; housing under the Charles Church brand name; and social housing under the Westbury Partnerships brand name. It also provides broadband services under the FibreNest brand; and timber frame, insulated wall panels, and roof cassettes under the brand Space4. Further, it offers concrete bricks and roof tile. Persimmon Plc was founded in 1972 and is headquartered in York, the United Kingdom.

Persimmon PLC

1330 O?Brien Drive, Menlo Park, CA, United States, 94025

Key Executives

Name Title Year Born
Mr. John Stephen West Co-Founder, CEO, Pres & Director 1957
Mr. Aaron L. Tachibana Sr. VP & CFO 1961
Dr. Richard Chen M.D., M.S., MS Sr. VP of R&D and Chief Medical Officer 1971
Dr. Russ B. Altman M.D., Ph.D. Co-Founder and Member of Clinical & Scientific Advisory Board NA
Dr. Euan A. Ashley DPHIL, FRCP, M.D., Ph.D. Co-Founder and Member of Clinical & Scientific Advisory Board 1972
Dr. Atul Butte Co-Founder and Member of Clinical & Scientific Advisory Board NA
Dr. Michael Snyder Ph.D. Co-Founder and Member of Clinical & Scientific Advisory Board NA
Ms. Carol J. Tillis VP of Fin. & Admin. NA
Mr. Stephen M. Moore J.D. VP, Gen. Counsel & Corp. Sec. 1972
Mr. Michael J Fitzpatrick VP of Worldwide Sales NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.